Estradiol attenuates hyperoxia-induced cell death in the developing white matter

Bettina Gerstner1, Marco Sifringer, Mark Dzietko

  • 1Department of Neonatology, Charité Campus Virchow-Klinikum, Berlin, Germany. bettina.gerstner@charite.de

Annals of Neurology
|April 13, 2007
PubMed

Insights

17beta-estradiol (E2) protects developing white matter from oxygen-induced injury in rat models. This estrogen treatment reduced cell death and preserved myelin, suggesting a potential role in preventing cerebral palsy.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Toxicology

Background:

  • Periventricular leukomalacia is a primary brain injury in preterm infants linked to cerebral palsy.
  • Oxygen toxicity is a suspected contributor to brain injury and cerebral palsy in preterm infants.
  • Estrogens, including 17beta-estradiol (E2), are known to have neuroprotective effects.

Purpose of the Study:

  • To investigate the effect of 17beta-estradiol (E2) on hyperoxia-induced cell death in the developing white matter of rat brains.
  • To determine if E2 can prevent oxygen-induced white matter injury in a neonatal rat model.

Main Methods:

  • Rat pups, oligodendrocyte cell lines, and primary cultures were exposed to 80% oxygen with or without E2.
  • Cell survival was assessed using cell counts and lactate dehydrogenase assays.
  • Apoptotic pathways, estrogen receptor expression, and myelin basic protein were analyzed.

Main Results:

  • E2 demonstrated dose-dependent protection against oxygen-induced apoptotic cell death in oligodendrocytes.
  • E2 treatment inhibited hyperoxia-induced upregulation of Fas and activation of caspase-3.
  • E2 prevented the inactivation of ERK1/2 and Akt survival pathways and attenuated myelin basic protein loss.

Conclusions:

  • Estrogens may play a role in preventing neonatal white matter injury caused by oxygen exposure.
  • E2's neuroprotective effects involve modulating apoptotic and survival signaling pathways.
  • These findings support the potential therapeutic use of estrogens in preterm infants at risk for brain injury.
Abstract